Edition:
United States

Profile: Antares Pharma Inc (ATRS.O)

ATRS.O on Consolidated Issue listed on NASDAQ Capital Market

2.09USD
17 Oct 2017
Change (% chg)

$-0.00 (-0.24%)
Prev Close
$2.10
Open
$2.10
Day's High
$2.14
Day's Low
$1.96
Volume
3,715,781
Avg. Vol
1,873,319
52-wk High
$4.09
52-wk Low
$1.41

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

Company Address

Antares Pharma Inc

SUITE 300, 100 PRINCETON SOUTH
EWING   NJ   8628
P: +1609.3593020
F: +1302.6555049

Company Web Links